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Abstract
The aim of the study is to assess the prognostic value of the structural and
functional echocardiographic indicators in IHD patients, depending on acute coronary
syndrome management (revascularization vs medical therapy), during 60 months.
Materials and methods:The total of 101 IHD patients were examined on the
clinical bases of the Internal Medicine Department 2. Prior to the study. The 84 males and
17 females aged 58.6±4.2were split into the experimental group after myocardial
revascularization (EG, n = 71) and control group with standard medical therapy (CG,
n = 30). In addition to the protocol-prescribed clinical lab tests, during five years, the
dynamics of the echocardiographic cardiac parameters has been assessed. The digital data
was processed by the Kaplan–Meier estimator; the 60-month cumulative survival rate (%)
was estimated and significance of the difference was assessed by Cox's F-test (p<0.05).
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Results and discussion.It appeared thatthe 5-year prognosis in IHD patients was
unaffected by the dimensions of IVST, LVIDD and LVMMI. In 60 months after the
surgery, a significantly better prognosis was observed for certain unfavourable initial
conditions: enlarged RV ≥ 2.5 cm (37.5% vs 30.7%, р = 0.008), aortic diameter ≥ 3.0 cm
(57.2% vs 34.3%, р = 0.02), enlarged LA ˃ 4.0 cm (43.8% vs 24.7%, р = 0.046). In
addition, revascularization was associated with better survival rates for normal LVMM
(<250 g; 75.8% vs 49.1%, р=0.05), without the thickening of the LV walls (66.9% vs
30.5%, р=0.047) and without LV systolic dysfunction (87.7% vs 59.9%, р=0.046). An
important place among the echocardiographic criteria of unfavourable prognosis belongs
to LV systolic dysfunction (EF ≤ 45%). Therefore, the experimental group patients were
distributed according to the EF value, following the Ukrainian Association of Cardiology
and EU guidelines, i.e. we singled out the so-called grey zone (EF=45-54%), where the
patients featuring LV systolic dysfunction and preserved EF belonged. The analysis of the
results showed the cumulative event-free survival to be 87.4% for EF ˃ 55%, 14.6% for
EF = 45-54% and 42.9% for EF < 45% (р = 0.01). The patients after the myocardial
revascularization with EF = 45-54% had a worse prognosis of event-free survival than
those with LV systolic dysfunction. In the group of patients who had undergone only the
medical therapy, the survival prognosis was significantly worse, which corresponded to a
reduced EF (38.3% for EF ˃ 55%, 15.0% for EF = 45-54% and 0% for EF < 45%, pEG-
CG = 0.01). A similar EF-based distribution was used in the study of patients with
decompensated heart failure (REDINSCOR II, 2017), in which the authors revealed that
the grey zone patients featured a higher risk of cardiovascular complications than patients
with normal EF values did.
Conclusions.Revascularization contributed to a considerably better 60-month
survival prognosis for cases featuring the enlarged right ventricle (≥2.5 cm), enlarged left
atrium (˃4.0 cm) and extended aortic root (≥3.0 cm), but with the normal left ventricular
myocardial mass (< 250 g) and without ventricular hypertrophy or systolic dysfunction.
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Introduction. In the medical literature, there are publications on the consequences
of revascularization in patients with ischemic heart disease (IHD) [1]. Regardless of
myocardial infarction management, structural and functional parameters of the heart
change in all patients, which results in the remodelling, i.e. in hypertrophy and dilation
with changes in the systolic and diastolic cardiac function [2,3]. Cardiac remodelling
involves first of all increased left ventricular mass (LVM), which often causes
cardiovascular complications [4,5]. As soon as in three months following myocardial
revascularization, the patients manifested with the left ventricular (LV) remodelling [6,7].
Thereat, a good prognosis in them correlated with the improved LV systolic function and
restored myocardial contractibility [8], and reduced LV ejection fraction is a marker of
poor survival [9,10]. The fact that the studies aimed at the analysis of survival prognosis
after myocardial revascularization are inconsiderable in number and mostly short-term
[1,8] adds to the importance of our research.
The aim of the study is to assess the prognostic value of the structural and
functional echocardiographic indicators in IHD patients, depending on acute coronary
syndrome (ACS) management (revascularization vs medical therapy), during 60 months.
Materials and methods: The total of 101 IHD patients (including ACS with ST
elevation with Q (48%), ST elevation without Q (28%), with no ST elevation (24%)) were
examined on the clinical bases of the Internal Medicine Department 2. Prior to the study,
written informed consent was obtained from all the enroleesin compliance with the
Declaration of Helsinki principles. The 84 males and 17 females aged 58.6±4.2 were split
into the experimental group after myocardial revascularization (EG, n=71) and control
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group with standard medical therapy (CG, n=30). In addition to the protocol-prescribed
clinical lab tests, during five years, the dynamics of the echocardiographic cardiac
parameters has been assessed, including the right ventricular diameter (RVD), left atrial
diameter (LAD), LV internal diastolic diameter (LVIDD), LV posterior wall thickness
(LVPWT) and interventricular septum thickness (IVST), aortic diameter and ejection
fraction (EF). The left ventricular myocardial mass (LVMM) was evaluated using the
Penn Convention, and its indexed value (LVMMI) and relative wall thickness (RWT)
were calculated [11]. The digital data was processed by the Kaplan–Meier estimator; the
60-month cumulative survival rate (%) was estimated and significance of the difference was
assessed by Cox's F-test (p<0.05). A case of hospitalization for repeated ACS, unstable angina
or chronic decompensated heart failure was considered an event.
Results and discussion. It appeared that the 5-year prognosis in IHD patients was
unaffected by the dimensions of IVST, LVIDD and LVMMI (Table 1).
Table 1 – Survival rates as a function of structural and functional heart parameters









Right ventricle ≤ 2.4 cm 66.8 52.5 ˃ 0.05≥ 2.5 cm 37.5 30.7 0.008
Aorta ≤ 2.9 cm 69.2 77.8 ˃ 0.05≥ 3.0 cm 57.2 34.3 0.02
Left atrium ≤ 4.0 cm 76.0 57.1 ˃ 0.05˃ 4.0 cm 43.8 24.7 0.046
Left ventricular internal
diastolic diameter
< 5.7 cm 65.7 54.3 ˃ 0.05
≥ 5.7 cm 35.1 0.0 ˃ 0.05
Interventricular septum
thickness
< 1.1 cm 68.3 24.2 ˃ 0.05
≥ 1.1 cm 54.6 52.9 ˃ 0.05
Left ventricular posterior
wall thickness
< 1.1 cm 66.9 30.5 0.047
≥ 1.1 cm 55.4 57.6 ˃ 0.05
Ejection fraction ˃ 50 % 87.7 59.9 0.046≤ 50 % 24.6 37.8 ˃ 0.05
Left ventricular myocardial
mass
< 250 g 75.8 49.1 0.05
≥ 250 g 40.1 31.8 ˃ 0.05
Left ventricular myocardial
mass index
< 115 cm/g 60.3 37.5 ˃ 0.05
≥ 115 cm/g 44.6 53.6 ˃ 0.05
Left ventricular relative
wall thickness
< 0.42 40.1 14.9 0.05
≥ 0.42 66.7 67.1 ˃ 0.05
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In 60 months after the surgery, a significantly better prognosis was observed for
certain unfavourable initial conditions: enlarged RV ≥2.5 cm (37.5% vs 30.7%, р=0.008)
(Fig. 1А), aortic diameter ≥ 3.0 cm (57.2% vs 34.3%, р=0.02), enlarged LA ˃ 4.0 cm
(43.8% vs 24.7%, р=0.046) (Fig. 1B).







































































Fig. 1. Survival of patients with enlarged right ventricle (A) and enlarged left atrium (B) depending
on management
In addition, revascularization was associated with better survival rates for normal
LVMM (<250 g; 75.8% vs 49.1%, р=0.05) (Fig.2), without the thickening of the LV walls
(66.9% vs 30.5%, р=0.047) and without LV systolic dysfunction (87.7% vs 59.9%,
р=0.046).
Fig. 2. Survival in patients with the left
ventricular myocardial mass below 250 g,
depending on management
EG LA˃4.0cm
CG RV≥ 2.5 cm
EG RV≥ 2.5 cm
CG LA˃4.0cm
CG LVMM< 250 g
EG LVMM< 250 g
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According to the literature data, a treatment method not taken into account, the
echocardiographic predictors of cardiovascular events in IHD patients include the enlarged
LA, dilated LV and reduced EF [9,10,12,13]. For instance, for the case of enlarged LV and
low EF, a three-year survival in IHD patients after the myocardial revascularization was
44.6%, whereas in the group where only medical therapy was administered it was 22%
[6,13], and for the cases with enlarged LV the patients’ survival was 65% versus 81% [12].
Our data show that there was no significant difference between the survival rates of
patients who underwent a conservative treatment and those after surgeries for different
values of LVIDD, LV wall thickness and EF below 50%. On the contrary, we found that
myocardial revascularization promotes a better prognosis even if there are already
unfavourable structural changes (Table 1, Fig.1A, B).
An important place among the echocardiographic criteria of unfavourable prognosis
belongs to LV systolic dysfunction (EF ≤45%) [9,10]. Therefore, the experimental group
patients were distributed according to the EF value, following the Ukrainian Association
of Cardiology and EU guidelines [11], i.e. we singled out the so-called grey zone (EF=45-
54%), where the patients featuring LV systolic dysfunction and preserved EF belonged
[14]. The analysis of the results showed the cumulative event-free survival to be 87.4% for
EF ˃ 55%, 14.6% for EF = 45-54% and 42.9% for EF < 45% (р = 0.01) (Fig. 3).
Fig. 3. Survival of patients after myocardial
revascularization depending on ejection
fraction
The patients after the myocardial revascularization with EF = 45-54% had a worse








































prognosis of event-free survival than those with LV systolic dysfunction. In the group of
patients who had undergone only the medical therapy, the survival prognosis was
significantly worse, which corresponded to a reduced EF (38.3% for EF ˃55%, 15.0% for
EF=45-54% and 0% for EF <45%, pEG-CG=0.01). A similar EF-based distribution was used
in the study of patients with decompensated heart failure (REDINSCOR II, 2017) [15], in
which the authors revealed that the grey zone patients featured a higher risk of
cardiovascular complications than patients with normal EF values did.
Conclusions. Revascularization contributed to a considerably better 60-month
survival prognosis for cases featuring the enlarged right ventricle (≥2.5 cm), enlarged left
atrium (˃4.0 cm) and extended aortic root (≥3.0 cm), but with the normal left ventricular
myocardial mass (<250 g) and without ventricular hypertrophy or systolic dysfunction.
The study can be extended to explore the reasons behind the worsening of the
prognosis in IHD patients whose left ventricular ejection fraction falls within the grey
zone.
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